Results 271 to 280 of about 507,322 (310)

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

New England Journal of Medicine, 2021
Anthony C Gordon, Paul Mouncey, Farah Al-Beidh   +2 more
exaly  

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis

New England Journal of Medicine, 2021
Allan L Klein, Massimo M Imazio, Antonio Luca Brucato   +2 more
exaly  

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A Dinarello, Anna Simon, Jos W M Van Der Meer   +2 more
exaly  

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

Nature Reviews Immunology, 2006
Thomas A Waldmann
exaly  

Interleukin-21: a double-edged sword with therapeutic potential

Nature Reviews Drug Discovery, 2014
Warren J Leonard
exaly  

Interleukin-22: Immunobiology and Pathology

Annual Review of Immunology, 2015
Jarrod A Dudakov, Alan Hanash, Marcel R M Van Den Brink   +2 more
exaly  

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, Peter Willeit, Pei Gao
exaly  

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Lancet, The, 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker   +2 more
exaly  

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

New England Journal of Medicine, 1987
W M Linehan
exaly  

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, César R Ramos-Remus   +2 more
exaly